SCHEMBL21048725

SCHEMBL21048725

CC(=O)C(COCc1ccccc1)CC(CC(=O)O)C(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 1/20 0.55
CPA1 P15085 2/20 0.46
CPB1 P15086 1/20 0.46
CPA3 P15088 1/20 0.46
CPB2 Q96IY4 1/20 0.46
MMP2 P08253 1/20 0.45
MMP12 P39900 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CA1 P00915 3/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
NPC1 O15118 1/20 0.44
LTA4H P09960 2/20 0.43
PSMB11 A5LHX3 1/20 0.43
PSMD11 O00231 1/20 0.43
PSMD12 O00232 1/20 0.43
PSMD14 O00487 1/20 0.43
PSMA7 O14818 1/20 0.43
PSMD3 O43242 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21048726 0.82 SLC1A1 (0.52) SLC1A1CPA1CPB1CPA3CPB2
SCHEMBL9449349 0.79 SLC1A1 (0.51) SLC1A1ALDH1A1CA1CA2CA7
SCHEMBL17884784 0.78 SLC1A1 (0.61) SLC1A1CPA1CPB1CPA3CPB2
SCHEMBL4433529 0.78 SLC1A1 (0.49) SLC1A1ALDH1A1CA1CA2CA7
SCHEMBL4433522 0.78 SLC1A1 (0.49) SLC1A1ALDH1A1CA1CA2CA7
SCHEMBL8839263 0.77 SLC1A1 (0.73) SLC1A1CPA1CPB1CPA3CPB2
SCHEMBL16743925 0.76 ALDH1A1 (0.52) SLC1A1ALDH1A1CA1CA2CA7
SCHEMBL4842363 0.76 CA1 (0.64) SLC1A1MMP2MMP12CA1CA2
SCHEMBL4836421 0.76 CA1 (0.64) SLC1A1MMP2MMP12CA1CA2
SCHEMBL4836414 0.76 CA1 (0.64) SLC1A1MMP2MMP12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3141601-B1 DOUBLE-CARBONYL REDUCTASE MUTANT AND APPLICATION OF SAME ASYMCHEM LAB TIANJIN CO LTD (CN) 2019-06-12 EP claimed